Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Minneapolis Firefighters' Relief Association v. Medtronic, Inc. et al
Case Number:
0:08-cv-06324
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Bernstein Litowitz
- Chestnut Cambronne
- Dorsey & Whitney
- Grant & Eisenhofer
- Gustafson Gluek
- Jones Day
- Kessler Topaz
- Kirkland & Ellis
- Lockridge Grindal
- Motley Rice
- Pomerantz LLP
- Robbins Geller
- Ropes & Gray
- Taft Stettinius
- WilmerHale
- Zimmerman Reed
Companies
Sectors & Industries:
-
April 02, 2012
Medtronic Will Pay Investors $85M To End Off-Label Suit
Medtronic Inc. has agreed to pay shareholders $85 million to settle a class action in Minnesota federal court alleging the medical device maker lied to investors about off-label marketing of its Infuse spinal graft system, the company said Friday.
-
February 02, 2012
Witness Must Testify In Medtronic Off-Label Suit: Judge
A Minnesota federal judge on Wednesday upheld a motion compelling a confidential witness to testify in a shareholder class action alleging Medtronic Inc.'s stock price dropped because the medical device company pushed off-label uses for its Infuse spinal graft.
-
December 12, 2011
Medtronic Investors Win Cert. In Off-Label Marketing Case
A Minnesota federal judge on Monday granted class certification to a group of shareholders alleging Medtronic Inc.'s stock value plunged because the company promoted off-label uses for its Infuse spinal graft system.
-
September 22, 2011
Medtronic Must Produce InFuse Docs In Securities Suit
After much back and forth, a Minnesota federal judge on Wednesday ordered Medtronic Inc. to turn over years of medical studies on the safety of the InFuse spinal graft as a class of shareholders tries to prove that the alleged off-label use of the device is what caused company stock to take a dive.